Viewing StudyNCT05017883



Ignite Creation Date: 2024-05-06 @ 4:32 PM
Last Modification Date: 2024-10-26 @ 2:12 PM
Study NCT ID: NCT05017883
Status: RECRUITING
Last Update Posted: 2021-11-04
First Post: 2021-08-17

Brief Title: TAA05 Cell Injection in the Treatment of Recurrent Refractory Acute Myeloid Leukemia
Sponsor: PersonGen BioTherapeutics Suzhou Co Ltd
Organization: PersonGen BioTherapeutics Suzhou Co Ltd

Organization Data

Organization: PersonGen BioTherapeutics Suzhou Co Ltd
Class: INDUSTRY
Study ID: V20
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: PersonGen BioTherapeutics Suzhou Co Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Anhui Provincial Hospital OTHER_GOV